4.10.26.3Vertical
Pediatric Speech & Language Therapy Centers
Practices specializing in language delays, articulation, autism communication, and childhood speech disorders.
Market snapshot
These figures describe Speech-Language Pathology (4.10.26), the segment that Pediatric Speech & Language Therapy Centers sits within — not Pediatric Speech & Language Therapy Centers on its own.
FragmentationConsolidatingEstimate
Within therapy offices (NAICS 621340) and pediatric services; the Census Bureau does not separate speech-language pathology, so the segment is not separately sized.
Business model & economics
Revenue model
Per-visit and per-session therapy reimbursement
Key economics
- Recurring revenue
- High
- EBITDA margin
- 12–22%
- Capex intensity
- Low
recurring multi-visit therapy
Characteristics
- Pediatric speech therapy an active roll-up area.
- Rising identification of pediatric needs.
- SLP shortage constrains supply.
M&A deal context
Deal activityModerate
Who’s acquiring
- Pediatric multi-therapy platforms
- PE-backed therapy consolidators
- Rehabilitation acquirers
What’s driving deals
- Pediatric multi-therapy roll-up.
- Rising pediatric-needs identification.
- SLP workforce constraints.
Find Pediatric Speech & Language Therapy Centers acquisition targets
Search Acquisera’s index for companies classified under Pediatric Speech & Language Therapy Centers (4.10.26.3) and build a targeted deal pipeline.
Search companies